D
Mineralys Therapeutics, Inc. MLYS
$14.89 $0.2751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 43.65% 42.53% 78.79% 62.19% 53.08%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 3.49% 25.69% 86.81% 128.77% 187.05%
Operating Income -3.49% -25.69% -86.81% -128.77% -187.05%
Income Before Tax -5.51% -33.97% -100.69% -147.55% -237.81%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -5.51% -33.97% -100.69% -147.55% -237.81%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -5.51% -33.97% -100.69% -147.55% -237.81%
EBIT -3.49% -25.69% -86.81% -128.77% -187.05%
EBITDA -3.48% -25.68% -- -- --
EPS Basic 20.43% -13.15% -61.06% -98.42% -172.10%
Normalized Basic EPS 20.45% -13.13% -61.05% -98.46% -172.08%
EPS Diluted 20.43% -13.15% -61.06% -98.42% -172.10%
Normalized Diluted EPS 20.45% -13.13% -61.05% -98.46% -172.08%
Average Basic Shares Outstanding 32.61% 18.40% 24.60% 24.75% 24.15%
Average Diluted Shares Outstanding 32.61% 18.40% 24.60% 24.75% 24.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --